ALDH1A1 and pancreatic neoplasm: It is worth mentioning that down-regulation of ALDH1, c-Rel and Nothc-1 as CSC markers by SFN, significantly elevates sensitivity of prostate and pancreas cancer cells to cisplatin, gemcitabine and 5-flourouracil chemotherapy [279].